- Home
- INZY vs CFBK Comparison
INZY vs CFBK Comparison
Compare INZY & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- CFBK
- Stock Information
- Founded
- INZY 2015
- CFBK 1892
- Country
- INZY United States
- CFBK United States
- Employees
- INZY N/A
- CFBK N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- CFBK Major Banks
- Sector
- INZY Health Care
- CFBK Finance
- Exchange
- INZY Nasdaq
- CFBK Nasdaq
- Market Cap
- INZY 188.2M
- CFBK 145.9M
- IPO Year
- INZY 2020
- CFBK 1998
- Fundamental
- Price
- INZY $1.36
- CFBK $22.85
- Analyst Decision
- INZY Strong Buy
- CFBK
- Analyst Count
- INZY 8
- CFBK 0
- Target Price
- INZY $17.75
- CFBK N/A
- AVG Volume (30 Days)
- INZY 784.0K
- CFBK 35.9K
- Earning Date
- INZY 03-11-2025
- CFBK 02-05-2025
- Dividend Yield
- INZY N/A
- CFBK 1.14%
- EPS Growth
- INZY N/A
- CFBK N/A
- EPS
- INZY N/A
- CFBK 2.04
- Revenue
- INZY N/A
- CFBK $44,396,000.00
- Revenue This Year
- INZY N/A
- CFBK N/A
- Revenue Next Year
- INZY N/A
- CFBK N/A
- P/E Ratio
- INZY N/A
- CFBK $11.18
- Revenue Growth
- INZY N/A
- CFBK N/A
- 52 Week Low
- INZY $1.32
- CFBK $16.92
- 52 Week High
- INZY $7.80
- CFBK $31.17
- Technical
- Relative Strength Index (RSI)
- INZY 20.27
- CFBK 40.04
- Support Level
- INZY $1.32
- CFBK $21.58
- Resistance Level
- INZY $3.18
- CFBK $22.99
- Average True Range (ATR)
- INZY 0.27
- CFBK 0.98
- MACD
- INZY -0.15
- CFBK -0.12
- Stochastic Oscillator
- INZY 2.15
- CFBK 33.62
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.